NGS Targeted Panel
Integrated Advantage NGS
Hospitals & IDN’s
Fast and Accurate
IMD Path is proud to announce with the acquisition of Pathology Services
Incorporated (PSI) laboratory in August of 2016, we are in the final stages of
validating our BD FACSCanto™ 10-Color “state of the art” Flow Cytometry system.
This 10-Color system will provide a range of efficient immunophenotyping services
that will measure a large number of makers simultaneously which essential in the
accurate assessment of leukemias and lymphomas.
Watch for the availability of this service, expected August 2017.
Blood, bone marrow, body fluid and tissue samples suspected of being involved by
leukemia or lymphoma undergo morphologic review. Multiparameter flow cytometric
immunophenotyping using antibody panels specifically designed to detect and
characterize hematologic malignancies is the method of choice for diagnosis and
evaluation of minimal residual disease (MRD) after treatment.
Minimal specimen requirements is another key benefit of our BD FACSCanto 10-Color Flow
Cytometry system and yet will provide maximal diagnostic/prognostic/predictive results along
MRD monitoring. For ease of analysis and to enable TC/PC capabilities for our Pathology
we will integrate FCS Express analysis software. With our affiliated Hematopathologists, we will
work with you to better understand and interpret your patients’ results in the context of
morphologic findings, provide information on clinical-pathologic correlations.
ensures accurate, timely diagnosis of your Bay Area Patients.
Sign Up for more information!
Register to received “Up-to-Date” information on Flow Cytometry
By using this site, you agree to the
Terms of Service